PEX26 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.668400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.631200E-01
Normal-vs-Stage2
7.590400E-01
Normal-vs-Stage3
2.299400E-01
Normal-vs-Stage4
5.676200E-01
Stage1-vs-Stage2
6.949200E-01
Stage1-vs-Stage3
1.367780E-01
Stage1-vs-Stage4
4.418000E-01
Stage2-vs-Stage3
2.190200E-01
Stage2-vs-Stage4
2.603000E-01
Stage3-vs-Stage4
1.493190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.130800E-01
Normal-vs-AfricanAmerican
7.181400E-01
Normal-vs-Asian
6.739800E-01
Caucasian-vs-AfricanAmerican
2.789000E-01
Caucasian-vs-Asian
7.376000E-01
AfricanAmerican-vs-Asian
3.664800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.049600E-01
Normal-vs-Female
8.333000E-01
Male-vs-Female
4.774400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.968100E-02
Normal-vs-Age(41-60Yrs)
9.632400E-01
Normal-vs-Age(61-80Yrs)
6.758800E-01
Normal-vs-Age(81-100Yrs)
5.819600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.685000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.234400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.723000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.201800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.395800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.515800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.658600E-01
Normal-vs-Daily Drinker
3.364400E-01
Normal-vs-Weekly Drinker
9.409000E-01
Normal-vs-Occasional Drinker
9.018200E-01
Normal-vs-Social Drinker
8.882000E-01
Non Drinker-vs-Daily Drinker
1.782410E-01
Non Drinker-vs-Weekly Drinker
7.270800E-01
Non Drinker-vs-Occasional Drinker
4.111600E-01
Non Drinker-vs-Social Drinker
7.146000E-01
Daily Drinker-vs-Weekly Drinker
1.755590E-01
Daily Drinker-vs-Occasional Drinker
5.502100E-02
Daily Drinker-vs-Social Drinker
1.117620E-01
Weekly Drinker-vs-Occasional Drinker
7.435000E-01
Weekly Drinker-vs-Social Drinker
9.728000E-01
Occasional Drinker-vs-Social Drinker
6.638200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.333200E-01
Normal-vs-Grade 2
5.470000E-02
Normal-vs-Grade 3
6.243600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.311800E-02
Grade 1-vs-Grade 3
8.792500E-02
Grade 1-vs-Grade 4
2.333200E-01
Grade 2-vs-Grade 3
9.017200E-01
Grade 2-vs-Grade 4
5.470000E-02
Grade 3-vs-Grade 4
6.243600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.435200E-01
Normal-vs-NonDiabetic
7.594200E-01
Diabetic-vs-NonDiabetic
4.602400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.833200E-01
Normal-vs-NoPancreatitis
7.445800E-01
Pancreatitis-vs-NoPancreatitis
8.079800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.211600E-01
Normal-vs-N1
8.134200E-01
N0-vs-N1
6.021000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.335800E-01
Normal-vs-TP53-NonMutant
9.226600E-01
TP53-Mutant-vs-TP53-NonMutant
7.456600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
